His primary areas of study are Immunology, Virology, Vaccine efficacy, AIDSVAX and Antibody. His Immunology study is mostly concerned with Vaccination, Vaccine trial, Immunogenicity, Immunity and Malaria. He works mostly in the field of Vaccination, limiting it down to topics relating to Internal medicine and, in certain cases, Acquired immunodeficiency syndrome, as a part of the same area of interest.
His study in Virology is interdisciplinary in nature, drawing from both Epitope, Monoclonal antibody and Immune system. His Vaccine efficacy research focuses on subjects like Antigen, which are linked to HIV Antigens. His AIDSVAX study integrates concerns from other disciplines, such as Regimen and Peptide sequence.
His primary scientific interests are in Immunology, Internal medicine, Virology, Antibody and Vaccination. As a part of the same scientific family, Punnee Pitisuttithum mostly works in the field of Immunology, focusing on HIV vaccine and, on occasion, Family medicine. His Internal medicine study combines topics in areas such as Surgery and Acquired immunodeficiency syndrome.
Punnee Pitisuttithum works mostly in the field of Virology, limiting it down to concerns involving AIDSVAX and, occasionally, Placebo. Punnee Pitisuttithum regularly links together related areas like Antigen in his Antibody studies. His studies deal with areas such as Young adult, Titer, Randomized controlled trial, Subclass and Reactogenicity as well as Vaccination.
Punnee Pitisuttithum mostly deals with Immunology, Antibody, Vaccination, Internal medicine and HIV vaccine. His work on Odds ratio expands to the thematically related Immunology. His studies deal with areas such as AIDSVAX, Immunity and Virology as well as Antibody.
His study on Live attenuated influenza vaccine is often connected to H5N1 vaccine as part of broader study in Vaccination. Punnee Pitisuttithum combines subjects such as Seroconversion and Immunogenicity with his study of Internal medicine. The concepts of his HIV vaccine study are interwoven with issues in Epitope, Canarypox, Herpes simplex virus and Vaccine efficacy.
Punnee Pitisuttithum spends much of his time researching Immunology, Antibody, Vaccination, Virology and HIV vaccine. His AIDSVAX research extends to the thematically linked field of Immunology. The Vaccination study combines topics in areas such as Placebo, Internal medicine and Immunogenicity.
His studies in Internal medicine integrate themes in fields like Booster dose, Seroconversion, Tetanus and Diphtheria. His research investigates the link between Virology and topics such as Antibody-dependent cell-mediated cytotoxicity that cross with problems in Cold sore, Mucosal immunology, Ex vivo, Isotype and Immunoglobulin class switching. His HIV vaccine research includes themes of Antigenicity, Antigen, Antigenic Diversity, Immunogen and Computational biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm;Punnee Pitisuttithum;Sorachai Nitayaphan;Jaranit Kaewkungwal.
The New England Journal of Medicine (2009)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes;Peter B. Gilbert;M. Juliana McElrath;Susan Zolla-Pazner.
The New England Journal of Medicine (2012)
A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
Elmar A. Joura;Anna R. Giuliano;Ole-Erik Iversen;Celine Bouchard.
The New England Journal of Medicine (2015)
Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
Maria Rosario Capeding;Ngoc Huu Tran;Sri Rezeki S. Harun Hadinegoro;Hussain Imam Hj Muhammad Ismail.
The Lancet (2014)
Randomized, Double‐Blind, Placebo‐Controlled Efficacy Trial of a Bivalent Recombinant Glycoprotein 120 HIV‐1 Vaccine among Injection Drug Users in Bangkok, Thailand
Punnee Pitisuttithum;Peter Gilbert;Marc Gurwith;William Heyward.
The Journal of Infectious Diseases (2006)
Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm
Melissa D. Simek;Wasima Rida;Frances H. Priddy;Pham Pung.
Journal of Virology (2009)
Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2
Arjen M Dondorp;Varunee Desakorn;Wirichada Pongtavornpinyo;Duangjai Sahassananda.
PLOS Medicine (2005)
Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies from an HIV-1 Vaccine Efficacy Trial Target Multiple Epitopes and Preferentially Use the VH1 Gene Family
Mattia Bonsignori;Justin Pollara;M. Anthony Moody;Michael D. Alpert.
Journal of Virology (2012)
Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination
Nicole L. Yates;Nicole L. Yates;Hua Xin Liao;Hua Xin Liao;Youyi Fong;Allan DeCamp.
Science Translational Medicine (2014)
Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2
Hua Xin Liao;Mattia Bonsignori;S. Munir Alam;Jason S. McLellan.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: